Workflow
Nephron Pharmaceuticals
icon
Search documents
豪威集团 三十而立奔赴“芯”征程
全球半导体行业持续复苏,高端手机图像传感器(CIS)和车载摄像头的需求继续增长……6月27日, 豪威集团举行2024年度暨2025年第一季度业绩暨现金分红说明会,豪威集团高管团队亮相,研判行业趋 势,诠释公司价值,就投资者关心的热点话题进行了互动问答。 三十而立奔赴"芯"征程 今年是豪威集团成立三十周年,不久前公司证券简称正式由"韦尔股份"变更为"豪威集团"。登陆A股市 场8年时间,豪威集团也开始布局证券化新征程。6月27日,公司宣布已向香港联交所递交发行境外上市 股份(H股)并在香港联交所主板挂牌上市的申请,有望开启"A+H"股的双资本平台运作模式。 "从'韦尔'到'豪威',变的是名称,不变的是对技术的敬畏之心与对创新的极致追求。"豪威集团总经理 王崧表示,站在豪威集团成立30周年的新起点,公司将继续以"赋能科技,感知无限"为使命,持续完善 全球化战略布局,充分发挥各业务体系之间的协同效应,携手客户为全球消费者创造更大的价值,持续 提升业务规模、市场竞争力,促进经营业绩稳健增长,为广大投资者创造长期价值回报。 智能手机和汽车市场齐头并进 "2024年,在全球半导体行业稳步复苏之际,我们凭借产品结构优化及供应 ...
Arbor Realty Trust: Don't Be Fooled By The 11.5% Dividend Yield
Seeking Alpha· 2025-06-27 19:49
There seem to be several reasons why the stock is struggling on the NYSE. Some of them include the Fed's delay in cutting interest rates, weak financialMr. Mavroudis is a professional portfolio manager specializing in institutional and private portfolios. He focuses on risk management, which is accompanied by in-depth financial market analysis (fundamental, macro and technical) to control the risk undertaken by the portfolios. He invests in all financial instruments globally (stocks, bonds, fx, commodities) ...
Cineverse Corp. (CNVS) Q4 2025 Earnings Conference Call Transcript
Seeking Alpha· 2025-06-27 19:46
Cineverse Corp. (NASDAQ:CNVS) Q4 2025 Earnings Conference Call Transcript June 27, 2025 9:00 AM ET Company Participants Christopher J. McGurk - Chairman & CEO Erick Opeka - President & Chief Strategy Officer Gary S. Loffredo - Chief Legal Officer, Secretary & Senior Advisor Mark Antonio Huidor - COO & CTO Mark Wayne Lindsey - Chief Financial Officer Conference Call Participants Brian David Kinstlinger - Alliance Global Partners, Research Division Daniel Louis Kurnos - The Benchmark Company, LLC, Research Di ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Altimmune, Inc. - ALT
Prnewswire· 2025-06-27 19:46
NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Altimmune, Inc. ("Altimmune" or the "Company") (NASDAQ: ALT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Altimmune and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On June 26, 2025, Altimm ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tesla, Inc. - TSLA
Prnewswire· 2025-06-27 19:46
NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tesla, Inc. ("Tesla" or the "Company") (NASDAQ: TSLA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Tesla and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]On June 22, 2025, Tesla debuted its ...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
Prnewswire· 2025-06-27 19:46
NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Hims & Hers and certain of i ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Edgewise Therapeutics, Inc. - EWTX
Prnewswire· 2025-06-27 19:46
NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Edgewise Therapeutics, Inc. ("Edgewise" or the "Company") (NASDAQ: EWTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.The investigation concerns whether Edgewise and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action]June 26, 2025 ...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEM
Prnewswire· 2025-06-27 19:46
NEW YORK, June 27, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Tempus AI, Inc. ("Tempus" or the "Company")(NASDAQ: TEM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Tempus and certain of its officers and/or ...
QuantumScape Soars 30%: What Drove the Next-Gen EV Stock's Rally
MarketBeat· 2025-06-27 19:38
QuantumScape TodayQSQuantumScape$6.53 -1.12 (-14.59%) 52-Week Range$3.40▼$9.52Price Target$5.19Add to WatchlistEV battery maker QuantumScape NYSE: QS just had one of its best days in a long time. On June 25, shares rocketed up around 30%, marking the stock’s biggest single-day gain since July 2024. The stock’s surge comes as the company announced the integration of its “Cobra Separator Process” into its battery production. QuantumScape is on a mission to build the EV battery technology of the future. So, w ...
Enerpac Tool(EPAC) - 2025 Q3 - Quarterly Report
2025-06-27 19:35
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ——————————— FORM 10-Q ———————————— (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File No. 1-11288 ———————————— ENERPAC TOOL GROUP CORP. (Exact name of registrant as specified in its charter) ———————————— Wisconsin 39-0168610 (State of i ...